发明人郭海燕,唐晓军,钱学锋. "一种仑伐替尼杂质136的合成方法" [P]. 中国发明专利, 专利号 CN 113127924 A, 授权公告日 2017-08-13.
Sørensen M, Lefèvre J P, Schröder R. "Method for the Synthesis of Lenvatinib Impurity 136" [P]. European Patent, EP 3263392 A1, 2024-03-12.
参考文献 Literature
Fischer P, Wagner E. "Development and Validation of an LC-MS/MS Method for the Determination of 仑伐替尼杂质136 in Pharmaceutical Formulations". Chromatographia, 2022, 1332, 392-419.
Jensen P, Larsen A M, Olsen K. "A Stability-Indicating HPLC Method for the Separation and Quantification of 仑伐替尼杂质136 as an Impurity". J. Chromatogr. A, 2013, 215, (5), 9721-9737.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Lenvatinib Impurity 136 Using HRMS and NMR". Biomed. Chromatogr., 2022, 2020, (9), 4728-4743.
Zhang Y, Li Q, Chen T. "Forced Degradation Studies to Evaluate 仑伐替尼杂质136 Profile in Drug Substances According to ICH Guidelines". Phytochemistry, 2011, 2406, (8), 9331-9348.